JON S FAIRFAX

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry HONOLULU, HI NPI 1053480152

General Payments — all program years on this page

$218.59

  • Category: General Payments
  • Program years: PY2018
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $218.59 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $218.5919

By paying entity

Latest program year (PY2018) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $104.3311
Lundbeck LLC $63.964
Sunovion Pharmaceuticals Inc. $50.304

By program year

Program yearAmountRecords
2018 $218.5919

Records — PY2018 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
567667311 Lundbeck LLC $17.75 04/20/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567667321 Lundbeck LLC $18.60 05/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567667327 Lundbeck LLC $15.56 07/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567667331 Lundbeck LLC $12.05 08/27/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589259546 Takeda Pharmaceuticals U.S.A., Inc. $6.43 07/23/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589422011 Takeda Pharmaceuticals U.S.A., Inc. $16.04 06/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589445332 Takeda Pharmaceuticals U.S.A., Inc. $9.28 01/26/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589876697 Takeda Pharmaceuticals U.S.A., Inc. $5.20 12/10/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589929467 Takeda Pharmaceuticals U.S.A., Inc. $5.33 05/07/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
590009861 Takeda Pharmaceuticals U.S.A., Inc. $17.93 10/17/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
590040769 Takeda Pharmaceuticals U.S.A., Inc. $11.89 02/05/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
590041129 Takeda Pharmaceuticals U.S.A., Inc. $6.64 06/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
590086007 Takeda Pharmaceuticals U.S.A., Inc. $13.36 05/14/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
590149063 Takeda Pharmaceuticals U.S.A., Inc. $5.33 05/07/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
590161279 Takeda Pharmaceuticals U.S.A., Inc. $6.90 06/27/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
607265571 Sunovion Pharmaceuticals Inc. $13.58 01/29/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
607265575 Sunovion Pharmaceuticals Inc. $12.99 05/09/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
607265581 Sunovion Pharmaceuticals Inc. $11.96 01/05/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
607265585 Sunovion Pharmaceuticals Inc. $11.77 10/24/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.